November marks COPD Awareness Month, and advocates this year will focus on action, and education about chronic obstructive ...

“Gloom, despair, and agony on me …” The Moonshiner quartet sang it best on the country show “Hee Haw,” their voices twanging through the television like a knowing wink from the universe. I used to ...

Although there is no cure for COPD yet, there are several approved treatments that can help manage the disease and ease symptoms. Learn more about some of the specific therapies used to treat this ...

Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder that causes several symptoms which make breathing difficult. These include persistent cough with mucus, wheezing, and shortness ...

It’s not uncommon for those of us with chronic obstructive pulmonary disease (COPD) to suffer from cachexia, or wasting disease. A 2019 study found that people with cachexia or pre-cachexia had a ...

The long-term use of aspirin was found to reduce the severity of acute exacerbations in chronic obstructive pulmonary disease (AECOPD), including in-hospital mortality, invasive ventilation use, and ...

Note: This is the first part of a three-part series written in collaboration with respiratory therapist Mark W. Mangus Sr., RRT, RPFT, FAARC, and oxygen expert Ryan Diesem. One of the more hotly ...

Chronic obstructive pulmonary disease, or COPD, is an inflammatory lung disease mainly caused by long-term exposure to irritants, such as cigarette smoke, air pollution, and chemical gases. In rare ...

The triple combination therapy is designed to alleviate the symptoms and reduce the frequency of COPD exacerbations — episodes in which disease symptoms suddenly worsen. All patients enrolled in the ...

A Phase 3 clinical trial testing AstraZeneca’s injection therapy benralizumab as a potential treatment for chronic obstructive pulmonary disease (COPD) has failed to meet its main goal of showing the ...

Using e-cigarettes, often called vaping, significantly increases the risk of chronic obstructive pulmonary disease (COPD), a U.S. study suggests. People who used e-cigarettes, which are ...

Dupixent (dupilumab) — a medication initially approved for exzema — was found to significantly reduce the number of disease exacerbations and to improve lung function in people with chronic ...